March 1, 2017

Amring Pharmaceuticals Inc. acquired six ANDA’s from Luitpold Pharmaceuticals, Inc. and AlphaForce, L.L.P., a joint venture between Luitpold Pharmaceuticals, Inc. and Alphagen Laboratories Inc.  The acquired ANDAs include niche otic and ophthalmic pharmaceuticals that will bring value to our customers and patients.
Read more

Amring
Products Partner Company LinkedIn
More news & events